4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001104659-21-130026
10% owner bought 187,500 shares at $16.00 ($3,000,000)
- 10% owner acquired 2,545,529 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Atlas Venture Fund XI, L.P. · 10% owner
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-26 | Conversion : show line 1 in the form | +1,372,998 | 1,399,313 | I | ||
| 2021-10-26 | Conversion : show line 2 in the form | +624,089 | 2,023,402 | I | ||
| 2021-10-26 | Conversion : show line 3 in the form | +548,442 | 548,442 | I | ||
| 2021-10-26 | Purchase : show line 4 in the form | +187,500 | $16.00 | $3,000,000 | 735,942 | I |
| Open-market purchases · 187,500 sh · avg $16.00 · $3,000,000 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-26 | Conversion : show line 5 in the form Series A1 Preferred Stock | −13,043,477 | 0 | I |
| 2021-10-26 | Conversion : show line 6 in the form Series B Preferred Stock | −5,928,852 | 0 | I |
| 2021-10-26 | Conversion : show line 7 in the form Series C Preferred Stock | −5,210,204 | 0 | I |
Loading xslF345X03/tm2130646-24_4seq1.xml…